Five volunteers have enrolled for the Covaxin phase 3 trials and were vaccinated first dose on Thursday. (File Photo) Coronavirus vaccine Covaxin update: Volunteers who have been administered dosage of Covaxin vaccine has not yet complained of any health issue or symptoms, said an official of a Gujarat-based hospital, which is conducting Phase 3 trial … Read more
Covaxin is conducting Phase III vaccine trails in India (File photo) India is waiting anxiously for Covaxin, the indigenously made Covid-19 vaccine, which started with its third phase trials in Odisha. As the Centre prepares for a mega drive, the vaccine maker recently reported to the Drug Controller General of India about a participant developing … Read more
Indigenous Coronavirus vaccine candidate Covaxin, jointly developed by Bharat Biotech and the Indian Council of Medical Research (ICMR), last week entered the third phase of the Human trial. Coronavirus vaccine update: Even as coronavirus cases in some parts of the country have been witnessing a sudden spike in the past few weeks, here’s a piece … Read more
After vaccines hit the market, people will still need to be careful in the same manner they are right now. While the Coronavirus outbreak globally is almost nearing a year, all eyes are set on the development and mass production of vaccines. Post vaccination, the fear of rapid COVID-19 transmission may go away; however, that … Read more
Bharat Biotech has been granted permission to start the Phase III trials of Covaxin – India’s indigenous Covid-19 vaccine candidate. [REPRESENTATIVE IMAGE] File photo of Covaxin (Picture Courtesy: Twitter @airnewsalerts) The Drug Controller General of India (DGCI) on Thursday allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate … Read more
Covaxin is considered as the country’s most promising one and is a frontrunner among COVID-19 vaccines. Moving ahead with the testing of vaccines for the novel Coronavirus, Bharat Biotech will start the second phase of human clinical trials of its indigenously developed Covaxin in the coming week. It has received clearance from the regulator body—Drugs … Read more
Covishield will only be commercialized after the trials that are being conducted right now are successful and all the required approvals for regulation have been given. Coronavirus vaccine: Serum Institute of India (SII), world’s largest vaccine manufacturer has taken out a statement denying the current claims of Covisheild’s availability in the next 73 days. According … Read more
NEW DELHI: Preliminary results of phase 1 clinical trials of the Bharat Biotech-ICMR developed Covid-19 vaccine, Covaxin, suggest that the vaccine is safe, principal investigators conducting the trials told ET. The vaccine is being tested on 375 volunteers who have enrolled at 12 sites in India. Two doses of the vaccine are being administered to … Read more